17α-Bromoprogesterone
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | 17α-BP; 17α-Bromopregn-4-ene-3,20-dione |
| Drug class | Progestogen; Progestin |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H29BrO2 |
| Molar mass | 393.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
17α-Bromoprogesterone (17α-BP) is a progestin which was first described in 1957 and was never marketed. It is about twice as potent as progesterone in terms of progestogenic activity in animal bioassays. 17α-BP is a parent compound of haloprogesterone (6α-fluoro-17α-bromoprogesterone) and 6α-methyl-17α-bromoprogesterone.